Powder: -20°C for 3 years | In solvent: -80°C for 1 year
GYKI-16638 is a novel antiarrhythmic agent that demonstrates combined class IB and class III antiarrhythmic properties in human ventricular muscles, similar to the electrophysiological findings after chronic amiodarone treatment. In addition, GYKI 16638 has an in vivo antiarrhythmic effect comparable to that of D-sotalol.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | $ 1,520.00 | |
50 mg | 6-8 weeks | $ 1,980.00 | |
100 mg | 6-8 weeks | $ 2,500.00 |
Description | GYKI-16638 is a novel antiarrhythmic agent that demonstrates combined class IB and class III antiarrhythmic properties in human ventricular muscles, similar to the electrophysiological findings after chronic amiodarone treatment. In addition, GYKI 16638 has an in vivo antiarrhythmic effect comparable to that of D-sotalol. |
Synonyms | GYKI 16,638, GYKI16,638, GYKI-16638, GYKI-16,638, GYKI16638, GYKI 16638 |
Molecular Weight | 459 |
Formula | C21H31ClN2O5S |
CAS No. | 307556-59-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
GYKI-16638 HCl 307556-59-8 GYKI 16,638 GYKI 16638 HCl GYKI16,638 GYKI-16638 GYKI-16,638 GYKI16638 GYKI16638 HCl GYKI 16638 inhibitor inhibit